APA

Yuan C., Guo X., Zhou Q., Du F., Jiang W., Zhou X., Liu P., Chi T., Ji X., Gao J., Chen C., Lang H., Xu J., Liu D., Yang Y., Qiu S., Tang X., Chen G. & Zou L. (20190812). OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice. : Biochimica et biophysica acta. Molecular basis of disease.

Chicago

Yuan Chunling, Guo Xiaoli, Zhou Qifan, Du Fangyu, Jiang Wei, Zhou Xiaoyu, Liu Peng, Chi Tianyan, Ji Xuefei, Gao Jinheng, Chen Chengwen, Lang Hongli, Xu Jia, Liu Danyang, Yang Yang, Qiu Shimeng, Tang Xing, Chen Guoliang and Zou Libo. 20190812. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice. : Biochimica et biophysica acta. Molecular basis of disease.

Harvard

Yuan C., Guo X., Zhou Q., Du F., Jiang W., Zhou X., Liu P., Chi T., Ji X., Gao J., Chen C., Lang H., Xu J., Liu D., Yang Y., Qiu S., Tang X., Chen G. and Zou L. (20190812). OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice. : Biochimica et biophysica acta. Molecular basis of disease.

MLA

Yuan Chunling, Guo Xiaoli, Zhou Qifan, Du Fangyu, Jiang Wei, Zhou Xiaoyu, Liu Peng, Chi Tianyan, Ji Xuefei, Gao Jinheng, Chen Chengwen, Lang Hongli, Xu Jia, Liu Danyang, Yang Yang, Qiu Shimeng, Tang Xing, Chen Guoliang and Zou Libo. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice. : Biochimica et biophysica acta. Molecular basis of disease. 20190812.